European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like The Effects of Prebiotic Supplementation with OMNi-LOGiC® FIBRE on Fecal Microbiome, Fecal Volatile Organic Compounds, and Gut Permeability in Murine Neuroblastoma-Induced Tumor-Associated Cachexia July 8, 2020 Galactooligosaccharide (GOS) Changes Fatty Acid Composition, Reduces Branched Short-Chain Fatty Acids, Ammonium in Colonic Fermentation Model January 18, 2023 Dietary fiber influences the gut microbiome and melanoma immunotherapy response January 3, 2022
The Effects of Prebiotic Supplementation with OMNi-LOGiC® FIBRE on Fecal Microbiome, Fecal Volatile Organic Compounds, and Gut Permeability in Murine Neuroblastoma-Induced Tumor-Associated Cachexia July 8, 2020
Galactooligosaccharide (GOS) Changes Fatty Acid Composition, Reduces Branched Short-Chain Fatty Acids, Ammonium in Colonic Fermentation Model January 18, 2023